AEON Biopharma, Inc. - Common Stock (AEON)

CUSIP: 00791X209

Q1 2026 13F Holders as of 31 Mar 2026

Security identity 2 facts
Shares outstanding
11,898,571
Holder snapshot 8 facts
Share change
+393,423
Reported price per share
$0.99
Number of holders
24
Value change
+$384,975
Number of buys
10
Number of sells
7

Security key

00791X209

Report period

Q1 2026

Institutions

24

Top holders

10

Ownership snapshot

Top reported holders of AEON - AEON Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Daewoong Co., Ltd
13D/G signal
Daewoong Co., Ltd
Evidence rows
15
Latest as of
21 Jan 2026
3/4/5 13D/G 13F Lead comparable stake: 50% 13D/G row: Daewoong Co., Ltd Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Daewoong Co., Ltd
3/4/5 13D/G
10%+ Owner · Daewoong Co.,Ltd. ("DWC")
50%
from 13D/G
$13,216,715
12,009,737 shares
21 Jan 2026
Jorey Chernett
13D/G
Chernett Jorey
9.9%
$564,250
1,128,500 shares
$0 27 May 2025
Dauntless Investment Group, LLC
13F 13D/G
Company
9.7%
from 13D/G
$1,324,924
2,131,852 shares
31 Dec 2025
BIGGER CAPITAL FUND L P
13D/G
Bigger Michael
6.1%
$343,000
4,900,000 shares
$0 06 Jan 2025
PALMISANO ROBERT J
13D/G 3/4/5
Robert J Palmisano · Director
5.7%
$158,550
2,265,000 shares
$0 25 Jul 2024
L1 Capital Global Opportunities Master Fund, Ltd.
13D/G
4.1%
$32,552
465,029 shares
-$594,648 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
24
Shares
2,841,419
Rows available
24
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
22
Q1 2026 holders
24
Holder diff
2
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .